Editas Medicine Inc Revenue per Employee (EDIT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Editas Medicine Inc   (NASDAQ: EDIT)
 

Editas Medicine Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 37.41% in the third quarter 2026, year on year to cumulative value of $50 million, Editas Medicine Inc 's revenue per employee grew on a trailing twelve months basis to $ 572,724. The productivity of Editas Medicine Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 208 other companies have achieved higher revenue per employee. While Editas Medicine Inc 's total ranking has deteriorated compared to the previous quarter from 726 to 1802. Editas Medicine Inc has 87 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EDIT Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 37.41 % 232.31 % -39.22 % -19.16 % 12265.57 %
Sales per Employee (TTM) $ 572,724 540,287 444,747 465,747 533,149
EDIT's Total Ranking # 1802 # 726 # 1897 # 0 #
Seq. Revenue Change -12.83 % 319.99 % -88.56 % 228 % 110.82 %

EDIT Company Profile >> Back to EDIT Efficiency Comparisons >> Compare EDIT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 29
Healthcare Sector # 209
Overall Market # 1802

Revenue per Employee Statistics
High Average Low
$ 1,052,839 $ 418,342 $ 64,816
(Sep 30 2020)   (Jun 30 2017)



Financial Statements
Editas Medicine Inc 's Revenue MRQ $ 10 Millions Visit EDIT's Income Statement
Editas Medicine Inc 's Revenues TTM $ 50 Millions Visit EDIT's aggregate revenue growth
What are EDIT's Sales? Visit EDIT's Sales by Segment




Other Ratios
Editas Medicine Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
EDIT's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for EDIT's Competitors
Revenue per Employee for EDIT's Suppliers
Revenue per Employee for EDIT's Customers

You may also want to know
EDIT's Sales Growth Rates EDIT's Pe Price to earnings ratio EDIT's Receivables Turnover Ratio EDIT's Stock Quote
EDIT's Net Income Growth Rates EDIT's Ps Price to Sales ratio EDIT's Sales per Employee EDIT's Asset Turnover Ratio
EDIT's Net Margin EDIT's Pb Price to Book ratio EDIT's Financial Strength Ratios EDIT's Dividend Payout Ratio
Date modified: 2026-11-10T05:35:31+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Verastem Inc   983,294.12 $ 100.296  Million 102 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 
Alphatec Holdings Inc   919,662.65 $ 839.652  Million 913 
Insmed Inc  888,846.15 $ 1,479.040  Million 1,664 
Carlisle Companies Incorporated  883,644.07 $ 5,213.500  Million 5,900 
Alkermes Plc   855,414.15 $ 1,753.599  Million 2,050 
Pfizer Inc  848,333.33 $ 63,625.000  Million 75,000 
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Beone Medicines Ltd   550,523.25 $ 6,606.279  Million 12,000 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.